Palisade Bio (PALI) Research & Development (2010 - 2026)

Palisade Bio (PALI) has reported Research & Development for 17 consecutive years, with $6.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Research & Development rose 531.58% year-over-year to $6.0 million; the TTM figure through Mar 2026 stood at $15.2 million (up 95.44% YoY), while the FY2025 annual figure was $10.2 million, up 12.46% from the prior year.
• Research & Development slipped to $6.0 million in Q1 2026 per PALI's latest filing, from $6.2 million in the prior quarter.
• Across five years, Research & Development topped out at $16.0 million in Q3 2024 and bottomed at -$11.8 million in Q4 2024.
• Historically, Research & Development has averaged $2.2 million across 5 years, with a median of $1.9 million in 2022.
• On a YoY basis, Research & Development climbed as much as 660.46% in 2024 and fell as far as 3353.87% in 2024.
• Palisade Bio's Research & Development stood at $2.3 million in 2022, then slumped by 84.55% to $362000.0 in 2023, then slumped by 3353.87% to -$11.8 million in 2024, then soared by 152.41% to $6.2 million in 2025, then dropped by 2.8% to $6.0 million in 2026.
• Business Quant data shows PALI's Research & Development at $6.0 million in Q1 2026, $6.2 million in Q4 2025, and $1.4 million in Q3 2025.